Chelsea Therapeutics International, Ltd. 3 SEC Filings

Filed On	Filing
30 Jan 2014	Form 3: Schmidt Keith, Chief Commercial Officer No securities owned
04 Feb 2011	Form 3: Venrock Healthcare Capital Partners Lp, 10% owner and 4 others Holds 5,114,934 shares of Common Stock
12 Jul 2010	Form 3: Venrock Healthcare Capital Partners Lp, 10% owner and 4 others Holds 3,107,944 shares of Common Stock
21 Jan 2010	Form 3: Roberts Michael J, VP, Business Development Holds 20,000 shares of Common Stock
27 Jul 2009	Form 3: Rueckert William Dodge, Director Holds 10,000 shares of Common Stock
30 Jun 2008	Form 3: Schwieterman William D, Director Holds 0 shares of No securities are beneficially owned
17 Jun 2008	Form 3: Oliveto Joseph, Vice President of Operations Holds 0 shares of No securities are beneficially owned
19 Feb 2008	Form 3: Hardman Norman Phd, Director Holds 0 shares of No shares are beneficially owned
19 Feb 2008	Form 3: Stoll Roger G Phd, Director Holds 0 shares of No shares are beneficially owned
02 Apr 2007	Form 3: Austin Josiah T, 10% owner and 1 other Holds 800 shares of Common Stock
05 Mar 2007	Form 3: Friedman Avram Z, 10% owner Holds 1,998,500 shares of Common Stock, $0.0001 par value ("Common Stock")
05 Mar 2007	Form 3: Kempner Thomas L Jr, 10% owner and 9 others Holds 1,998,500 shares of Common Stock, $0.0001 par value ("Common Stock")
05 Mar 2007	Form 3: Davidson Kempner Partners, 10% owner and 9 others Holds 1,998,500 shares of Common Stock, $0.0001 par value ("Common Stock")
16 Feb 2007	Form 3: Schmidt Keith, Vice Pres. Marketing and Sales
01 Mar 2006	Form 3: HealthCor Management, L.p., 10% owner and 2 others Holds 64,678 shares of Common Stock

Comments